ADVERSE REACTIONS
See BOX WARNINGS, WARNINGS, and PRECAUTIONS.
Premarin Intravenous is indicated for short-term use. However, the warnings, precautions and adverse reactions associated with Premarin tablets should be taken into account.
- Genitourinary system.
Changes in vaginal bleeding pattern and abnormal withdrawal bleeding or flow; breakthrough bleeding, spotting.
Increase in size of uterine leiomyomata.
Vaginal candidiasis.
Change in amount of cervical secretion.
- Breasts.
Pain, tenderness, enlargement.
- Cardiovascular.
Venous thrombosis.
Pulmonary embolism.
Superficial thrombophlebitis.
Hypotension.
Myocardial infarction.
Stroke.
- Gastrointestinal.
Nausea, vomiting.
Abdominal cramps, bloating.
Cholestatic jaundice.
Increased incidence of gallbladder disease.
Pancreatitis.
Enlargement of hepatic hemangiomas. - Skin.
Chloasma or melasma that may persist when drug is discontinued.
Erythema multiforme.
Erythema nodosum.
Hemorrhagic eruption.
Loss of scalp hair.
Hirsutism.
Pruritis.
Rash.
- Eyes.
Retinal vascular thrombosis.
Intolerance to contact lenses. - Central Nervous System.
Headache.
Migraine.
Dizziness.
Mental depression.
Chorea.
Nervousness.
Exacerbation of epilepsy.
Dementia.
- Miscellaneous.
Increase or decrease in weight.
Reduced carbohydrate tolerance.
Aggravation of porphyria.
Edema.
Changes in libido.
Anaphylactoid/anaphylactic reactions.
Urticaria.
Angioedema.
Injection site pain.
Injections site edema.
Phlebitis (injection site).
Exacerbation of asthma.
|